Group 1 - The core viewpoint of the article highlights that *ST Huifeng (002496) has experienced revenue growth but significant profit decline in its 2025 mid-year report, indicating a challenging financial situation [1] - The company's total operating revenue reached 157 million yuan, a year-on-year increase of 42.6%, while the net profit attributable to shareholders was 11.47 million yuan, a year-on-year decrease of 67.02% [1] - The gross profit margin was reported at 10.01%, down 65.83% year-on-year, and the net profit margin was 5.58%, down 82.21% year-on-year, reflecting deteriorating profitability [1] Group 2 - The company reported a significant increase in sales expenses, management expenses, and financial expenses totaling 57.27 million yuan, which accounted for 36.47% of revenue, a decrease of 42.54% year-on-year [1] - The earnings per share (EPS) decreased to 0.01 yuan, down 67.1% year-on-year, indicating a decline in shareholder returns [1] - The company's historical financial performance has been poor, with a median return on invested capital (ROIC) of -8.51% over the past decade, and a particularly low ROIC of -23.34% in 2023 [3]

Group 1 - The core point of the article is that *ST Huifeng (002496.SZ) released its semi-annual report for 2025, indicating the current status of institutional ownership [1] - As of August 26, 2025, there is one institutional investor holding shares in *ST Huifeng, with a total holding of 30.5953 million shares, representing 2.03% of the total share capital [1] - The institutional investor includes Jiangsu Huifeng Biological Agriculture Co., Ltd. - Phase I Employee Stock Ownership Plan, maintaining the same holding percentage [1]

Core Viewpoint - *ST Huifeng reported a significant increase in revenue but a substantial decline in net profit for the first half of 2025, indicating challenges in profitability despite higher sales [1] Financial Performance - The total operating revenue for the first half of 2025 reached 157 million yuan, a year-on-year increase of 42.6% compared to 110 million yuan in the same period of 2024 [1] - The net profit attributable to shareholders was 11.47 million yuan, reflecting a year-on-year decrease of 67.02% from 34.76 million yuan [1] - The gross profit margin fell to 10.01%, a decrease of 65.83% from 29.28% in the previous year [1] - The net profit margin also declined to 5.58%, down 82.21% from 31.38% [1] - The total of selling, administrative, and financial expenses was 57.27 million yuan, accounting for 36.47% of revenue, a decrease of 42.54% year-on-year [1] Cash Flow and Financial Health - The company reported a negative operating cash flow per share of -0.01 yuan, a drastic decline of 1519.86% compared to the previous year [1] - The cash and cash equivalents decreased slightly to 43.29 million yuan, down 2.66% from 44.47 million yuan [1] - The accounts receivable increased by 19.14% to 46.07 million yuan, indicating potential issues with cash collection [1] Investment Return Metrics - The historical median Return on Invested Capital (ROIC) over the past decade was -8.51%, with the worst year being 2023 at -23.34%, indicating poor investment returns [3] - The company has reported losses in 6 out of its 14 annual reports since going public, suggesting a lack of consistent profitability [3]

非经营性资金占用及其他关联资金往来情况汇总表 2025年半年度 | 编制单位：江苏辉丰生物农业股份有限公司 | | | | | | | | | | 单位：人民币万元 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司的 | 上市公司核算的 | 2025年期初 | 2025年度往来累计 发生金额 | 2025年度往来资金 的利息 | 2025年度偿还累计发 | 2025年期末 | 占用形成原因 | 占用性质 | | | | 关联关系 | 会计科目 | 往来资金余额 | （不含利息） | （如有） | 生金额 | 往来资金余额 | | | | 控股股东、实际控制人及其附属企业 | | | | | | | | | | | | | | | | | | | | | | 非经营性占用 | | 小 计 | - | - | - | | | | | | | - | | 前控股股东、实际控制人及其附属企 | | | | | | | | | | | | 业 | | | | | | ...

江苏辉丰生物农业股份有限公司 2025 年半年度财务报告 （未经审计） 2024 年 8 月 2025 年半年度财务报告 目 录 | | | | | | 第 1页共 137 页 2025 年半年度财务报告 2025 年半年度财务报表 1、合并资产负债表 编制单位：江苏辉丰生物农业股份有限公司 2025 年 06 月 30 日 单位：元 | 项目 | 期末余额 | 期初余额 | | --- | --- | --- | | 流动资产： | | | | 货币资金 | 43,290,937.99 | 28,510,902.36 | | 结算备付金 | | | | 拆出资金 | | | | 交易性金融资产 | | | | 衍生金融资产 | | | | 应收票据 | | | | 应收账款 | 46,074,812.78 | 81,238,491.24 | | 应收款项融资 | 2,971,130.01 | 6,250,480.48 | | 预付款项 | 109,284,593.96 | 35,572,194.97 | | 应收保费 | | | | 应收分保账款 | | | | 应收分保合同准备金 | | | | 其他应收 ...

特别提示 一、 会议召开和出席情况 1、 召开时间：2025 年 8 月 25 日（星期一）14:00 6、 会议通知情况：公司董事会已于 2025 年 8 月 5 日在《中国证券报》、《证 券时报》和巨潮资讯网（http://www.cninfo.com.cn）上刊登了《关于召开 2025 年 第二次临时股东会的通知》（2025-033），公告了 2025 年第二次临时股东会审议 的事项及投票表决的方式和方法等。 证券代码：002496 证券简称：*ST 辉丰 公告编号：2025-035 江苏辉丰生物农业股份有限公司 2025 年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 7、 本次会议的召集、召开符合《中华人民共和国公司法》、《上市公司股 东大会规则》、《深圳证券交易所股票上市规则》等有关法律、行政法规、部门规 章、规范性文件和《江苏辉丰生物农业股份有限公司章程》的有关规定。 8、 会议出席情况 （1） 股东总体出席情况 通过现场和网络投票的股东 319 人，代表股份 462,881,507 股，占上市公司 总股份的 30.7 ...

江苏涤非律师事务所 关于江苏辉丰生物农业股份有限公司 2025 年第二次临时股东会的 法 律 意 见 书 〔2025〕苏涤证券字第 03 号 致：江苏辉丰生物农业股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、中国证券监督管理委员会《上市公司股东会规则》（2025 年 修订，以下简称"《股东会规则》"）及《深圳证券交易所上市公司股东会网络投票实施 细则(2025 年修订)》（以下简称"《网络投票实施细则》"）等法律、法规及规范性文件的 规定，江苏涤非律师事务所（以下简称 "本所"）指派孙俐律师、潘春香律师出席江苏 辉丰生物农业股份有限公司（以下简称"公司"）2025 年第二次临时股东会（以下简称 "本次股东会"），并对本次股东会的相关事项进行见证。 为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1．公司章程； 2．公司第九届董事会第十次临时会议决议公告； 7．本次股东会的会议文件。 1 3．公司关于聘任 2025 年度审计机构的议案； 4．公司关于拟聘任 2025 年度审计机构的公告； 5．公司关于召开 202 ...

江苏辉丰生物农业股份有限公司 2025 年半年度报告全文 江苏辉丰生物农业股份有限公司 2025 年半年度报告 【2025 年 8 月】 1 江苏辉丰生物农业股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人仲汉根、主管会计工作负责人周京及会计机构负责人(会计主 管人员)王普国声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 公司存在经营风险，敬请广大投资者注意投资风险。详细内容见本报告 第三节 十 "公司面临的风险和应对措施"。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | | | | 第一节 | 重要提示、目录和释义 | 2 | | | --- | --- | --- | --- | | 第二节 | 公司简介和主要财务指标 | | 6 | | 第三节 | 管理层讨论与分析 | | 9 | | 第四节 | 公司治理、环境和社会 | 16 | | | 第五 ...

Group 1 - The company held its ninth board meeting on August 5, 2025, to discuss various proposals [2][4] - The board approved the appointment of Suya Jincheng as the auditing firm for the 2025 fiscal year, replacing Tianjian Accounting Firm [4][11] - The board also approved the extension of the first employee stock ownership plan until August 11, 2026, with no shares sold to date [28][29] Group 2 - The board meeting's resolutions will be submitted for approval at the second extraordinary shareholders' meeting scheduled for August 25, 2025 [5][7] - The company has communicated with both the outgoing and incoming auditing firms regarding the change, ensuring no objections were raised [21][22] - The company’s first employee stock ownership plan currently holds 30,595,320 shares, representing approximately 2.03% of the total shares [29]

Group 1 - The board of directors of Jiangsu Huifeng Bio-Agriculture Co., Ltd. held its tenth temporary meeting on August 5, 2025, with all nine directors participating [1][2]. - The meeting approved the proposal to appoint Suya Jincheng as the auditing firm for the company's 2025 financial report and internal control audit services, with a term of one year [1][2]. - The proposal received unanimous support with 9 votes in favor, and it will be submitted for review at the company's second temporary shareholders' meeting in 2025 [2]. Group 2 - The independent directors expressed their agreement with the decisions made during the board meeting, and their opinions were disclosed on the same day [2]. - The meeting's proceedings complied with the relevant laws and regulations, ensuring the independence and objectivity of the audit services [1]. - The company will publish further details regarding the appointment of the auditing firm and the upcoming shareholders' meeting on various financial news platforms [2].